-
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
-
Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation
-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
-
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs – Invitation to Business Update on April 17, 2024
-
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024
-
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024
-
Ultimovacs ASA: Mandatory notification of trade by primary insider
